Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Computype And Wheaton Partnering on Labware

June 28, 2011 7:41 am | News | Comments

Computype, Inc. and Wheaton Industries have partnered to help biopharmaceutical companies improve standard laboratory processes such as sample tracking and inventory management through the use of pre-labeled 2D barcoded glass microtubes.


Breakthrough Heralds Improved Allergy Treatments

June 28, 2011 7:33 am | News | Comments

An international team of scientists using Diamond Light Source, the UK’s national synchrotron facility, has successfully solved the complex 3D structure of the human Histamine H1 receptor protein.


Phase 2 Trial of HinsBet Begins

June 28, 2011 7:25 am | News | Comments

Adocia SAS, a biotechnology company specialized in regenerative medicine and in the treatment of chronic diseases, announced the launch of its second clinical trial for the development of HinsBet, a fast-acting human insulin.


FDA Panel Backs FIRAZYR Approval

June 28, 2011 7:19 am | News | Comments

Shire plc announced that a Food and Drug Administration advisory panel supported approval of FIRAZYR for the treatment of acute attacks of hereditary angioedema.


Apricus Reconsidering MycoVa Indication

June 28, 2011 7:07 am | News | Comments

Apricus Biosciences Inc. said it is reconsidering its regulatory strategy for its foot fungus treatment MycoVa, indicating it may seek approval to market the drug for patients who don't have athlete's foot.


Pre-Configured Sequencing Systems

June 28, 2011 7:05 am | Product Releases | Comments

GenoLogics’s pre-configured version of its LIMS software for Illumina next-generation sequencing (NGS) systems and TruSeq Sample Prep Kits speeds implementation time for labs with Illumina systems and provides users with the flexibility to interface with other genomics systems. An application programming interface (API) allows users to extend the LIMS to accommodate future changes in the lab.


Pfizer Applies for Axitinib Approval

June 28, 2011 7:04 am | News | Comments

Pfizer Inc. said it filed for marketing approval of its drug candidate axitinib as a treatment for advanced renal cell carcinoma, the most common type of kidney cancer.


Gilead, J & J Working on HIV Pills

June 28, 2011 7:01 am | News | Comments

Gilead Sciences Inc. and Johnson & Johnson have agreed to collaborate on a pill that combines Johnson & Johnson's HIV drug Prezista with Gilead's drug candidate cobicistat, which is designed to make other anti-retroviral drugs more effective.


Run Manager Interface Solution

June 28, 2011 7:00 am | Product Releases | Comments

Two Fold Software Limited, has enhanced the interface design and user friendliness of the Run Manager software module of its Qualoupe LIMS solution to enable users to set up queues of samples to be processed through a specific laboratory instrument for a given method.


PAT Tool Connectivity

June 28, 2011 6:56 am | Product Releases | Comments

Expo Technologies and Umetrics Inc. developed Expo’s NovaMath 5.0, which can use models built in SIMCA- P+ by the SIMCA-QP tool.


Monthly Dose of Exenatide Meets Glycemic Control Target

June 28, 2011 6:50 am | News | Comments

Amylin Pharmaceuticals, Inc., Eli Lilly and Company, and Alkermes, Inc. announced additional results from a Phase 2 study of an investigational, once-monthly injectable suspension formulation of exenatide that showed substantial improvements in glycemic control, including reductions in A1C and fasting plasma glucose, with modest weight loss.


Data Comparing Linagliptin and Glimepiride Revealed

June 28, 2011 6:44 am | News | Comments

Boehringer Ingelheim and Eli Lilly and Company announced results demonstrating linagliptin was as effective at lowering blood sugar as glimepiride, and with weight loss instead of weight gain, a lower incidence of investigator-defined hypoglycemia.


Symlin Delivered via Insulin Pump Reduces Symptoms

June 28, 2011 6:39 am | News | Comments

Amylin Pharmaceuticals, Inc. announced data from a new analysis characterizing the effects of Symlin (pramlintide acetate) injection in patients with type 1 diabetes who used insulin pumps during two completed clinical studies.


Dapagliflozin with Metformin XR Reduced Blood Sugar Levels

June 28, 2011 6:33 am | News | Comments

Bristol-Myers Squibb and AstraZeneca announced results from two 24-week Phase 3 clinical studies examining the investigational compound dapagliflozin at 5 mg or 10 mg (clinical trial dose) plus metformin extended-release (XR).


Prescription Medical Food Improves Patient Symptoms

June 28, 2011 6:28 am | News | Comments

Results from a clinical trial presented at the American Diabetes Association 71st Scientific Sessions (ADA), suggests that nutritional management of diabetic neuropathy with L-methylfolate, methylcobalamin, and pyridoxal 5’-phosphate, a prescription medical food dispensed by prescription and commercially as Metanx, improves total symptoms and health related quality of life.



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.